Phase 3 Clinical Trial Comparing the Efficacy of an Investigational Medication Combined with Daratumumab or Daratumumab and Pomalidomide Versus Daratumumab, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma.

What's the purpose of the trial?

The goal of this clinical trial is to learn more about the efficacy of an investigational medication when combined with either Daratumumab and Pomalidomide or Daratumumab alone, and compare the efficacy to another regimen, Daratumumab, Pomalidomide and Dexamethasone. 

Trial status

Accepting patients

Phase 3
Last Updated
3 months ago
Am I Eligible

Participating Centers

There are 40 centers participating in this trial. Enter a location below to find the closest center.

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.